227 related articles for article (PubMed ID: 27188706)
1. Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.
Abramowitz J; Thakkar P; Isa A; Truong A; Park C; Rosenfeld RM
Otolaryngol Head Neck Surg; 2016 Oct; 155(4):547-54. PubMed ID: 27188706
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
[TBL] [Abstract][Full Text] [Related]
3. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
[TBL] [Abstract][Full Text] [Related]
5. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors: potential adverse effects.
Abraham NS
Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
[TBL] [Abstract][Full Text] [Related]
8. Perils and pitfalls of long-term effects of proton pump inhibitors.
Wilhelm SM; Rjater RG; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
10. Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
Islam MM; Poly TN; Walther BA; Dubey NK; Anggraini Ningrum DN; Shabbir SA; Jack Li YC
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1395-1405. PubMed ID: 30028775
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
Naito Y; Kashiwagi K; Takagi T; Andoh A; Inoue R
Digestion; 2018; 97(2):195-204. PubMed ID: 29316555
[TBL] [Abstract][Full Text] [Related]
13. Considerations for the use of proton-pump inhibitors in older adults.
Desilets AR; Asal NJ; Dunican KC
Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
[TBL] [Abstract][Full Text] [Related]
14. Complications of Proton Pump Inhibitor Therapy.
Vaezi MF; Yang YX; Howden CW
Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
[TBL] [Abstract][Full Text] [Related]
15. Indications and safety of proton pump inhibitor drug use in patients with cancer.
Triadafilopoulos G; Roorda AK; Akiyama J
Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
[TBL] [Abstract][Full Text] [Related]
16. [Potential risks associated with long-term PPI use].
Kamiya T
Nihon Rinsho; 2016 Aug; 74(8):1387-1391. PubMed ID: 30562448
[TBL] [Abstract][Full Text] [Related]
17. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.
Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL
J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
Singh A; Cresci GA; Kirby DF
Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method.
Yucel E; Sancar M; Yucel A; Okuyan B
Expert Opin Drug Saf; 2016; 15(2):223-36. PubMed ID: 26635063
[TBL] [Abstract][Full Text] [Related]
20. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]